WHWK
Whitehawk Therapeutics, Inc. - Common Stock (WHWK)
$76
About Whitehawk Therapeutics, Inc. - Common Stock (WHWK)
Whitehawk Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai in November 2007 and is headquartered in Morristown, NJ.
Details
Daily high
$4.82
Daily low
$4.59
Price at open
$4.59
52 Week High
$5.50
52 Week Low
$1.57
Market cap
264.5M
Dividend yield
-
Volume
151,603
Avg. volume
470,366
P/E ratio
-4.17
Whitehawk Therapeutics, Inc. - Common Stock News
Details
Daily high
$4.82
Daily low
$4.59
Price at open
$4.59
52 Week High
$5.50
52 Week Low
$1.57
Market cap
264.5M
Dividend yield
-
Volume
151,603
Avg. volume
470,366
P/E ratio
-4.17